These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 21681905)

  • 21. Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors.
    De Luca G; Gibson M; Cutlip D; Huber K; Dudek D; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Secco GG; Mesquita Gabriel H; Emre A; Arntz HR; Rakowski T; Gyongyosi M; Hof AW;
    Arch Cardiovasc Dis; 2013 Mar; 106(3):155-61. PubMed ID: 23582677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Wijnbergen I; Tijssen J; van 't Veer M; Michels R; Pijls NH
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):379-84. PubMed ID: 23553888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents.
    Kubo M; Miyoshi T; Oe H; Ohno Y; Nakamura K; Ito H
    BMC Cardiovasc Disord; 2015 Sep; 15():102. PubMed ID: 26399321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
    Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year.
    Stolker JM; Cohen DJ; Kennedy KF; Pencina MJ; Lindsey JB; Mauri L; Cutlip DE; Kleiman NS;
    Circ Cardiovasc Interv; 2012 Dec; 5(6):772-82. PubMed ID: 23093553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of clinical outcomes between first-generation and second-generation drug-eluting stents in type 2 diabetic patients.
    Jeong HS; Cho JY; Kim EJ; Yu CW; Ahn CM; Park JH; Hong SJ; Lim DS
    Coron Artery Dis; 2013 Dec; 24(8):676-83. PubMed ID: 23994881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Impact of OCT Findings During PCI: The CLI-OPCI II Study.
    Prati F; Romagnoli E; Burzotta F; Limbruno U; Gatto L; La Manna A; Versaci F; Marco V; Di Vito L; Imola F; Paoletti G; Trani C; Tamburino C; Tavazzi L; Mintz GS
    JACC Cardiovasc Imaging; 2015 Nov; 8(11):1297-305. PubMed ID: 26563859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term clinical outcomes with the use of a modified provisional jailed-balloon stenting technique for the treatment of nonleft main coronary bifurcation lesions.
    Depta JP; Patel Y; Patel JS; Novak E; Yeung M; Zajarias A; Kurz HI; Lasala JM; Bach RG; Singh J
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E637-46. PubMed ID: 23420654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention.
    Rechciński T; Jasińska A; Foryś J; Krzemińska-Pakuła M; Wierzbowska-Drabik K; Plewka M; Peruga JZ; Kasprzak JD
    Cardiol J; 2013; 20(5):491-8. PubMed ID: 24469872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.
    Jones DA; Rathod KS; Gallagher S; Weerackody R; Knight CJ; Rothman MT; Mathur A; Jain AK; Timmis AD; Wragg A
    Catheter Cardiovasc Interv; 2013 May; 81(6):E237-44. PubMed ID: 22707383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
    Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
    Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden.
    Ke D; Zhong W; Fan L; Chen L
    Coron Artery Dis; 2012 Nov; 23(7):497-506. PubMed ID: 22968214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
    Harskamp RE; Beijk MA; Damman P; Kuijt WJ; Woudstra P; Grundeken MJ; Kloek JJ; Tijssen JG; de Mol BA; de Winter RJ
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):438-45. PubMed ID: 22828774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term clinical outcomes after unprotected left main coronary artery stenting in an all-comers patient population.
    Ali M; Hanley A; McAdam B; O'Hanlon R; Gumbrielle T; Sheahan R; Foley DP
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E411-8. PubMed ID: 23404813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
    Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
    Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The independent value of a direct stenting strategy on early and late clinical outcomes in patients undergoing elective percutaneous coronary intervention.
    Sardi GL; Laynez-Carnicero A; Torguson R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Catheter Cardiovasc Interv; 2013 May; 81(6):949-56. PubMed ID: 22888029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus.
    Badr S; Minha S; Kitabata H; Fatemi O; Torguson R; Suddath WO; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):192-8. PubMed ID: 24585520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes in patients with renal impairment undergoing percutaneous coronary intervention and implantation of the Endeavor zotarolimus-eluting stent: 1- and 2-year data from the E-Five Registry.
    Rothman MT; Jain AK;
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):885-92. PubMed ID: 22517785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Six-year clinical outcomes of first-generation drug-eluting stents: a propensity-matched analysis.
    Tarantini G; Barioli A; Facchin M; Frigo AC; Napodano M; Buja P; D'Amico G; Iliceto S; Isabella G
    Coron Artery Dis; 2013 Aug; 24(5):440-8. PubMed ID: 23695366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.